当前位置:首页 - 行情中心 - 达安基因(002030) - 财务分析 - 现金流量表

达安基因

(002030)

  

流通市值:77.19亿  总市值:77.19亿
流通股本:14.03亿   总股本:14.03亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金458,213,148.82209,327,655.561,237,264,874.67813,245,333.21
  收到的税费返还396,286.82150,359.32644,902.39490,522.75
  收到其他与经营活动有关的现金183,175,255.78103,371,358.66663,271,502.58522,791,928.21
  经营活动现金流入小计641,784,691.42312,849,373.541,901,181,279.641,336,527,784.17
  购买商品、接受劳务支付的现金159,824,461.1188,984,150.74461,754,432.73326,708,733.98
  支付给职工以及为职工支付的现金212,340,993128,099,894.38363,597,158.34344,383,640.66
  支付的各项税费13,718,114.266,468,338.3529,802,684.7431,500,976.53
  支付其他与经营活动有关的现金230,217,387.13134,930,638.11726,537,750.47552,416,531.45
  经营活动现金流出小计616,100,955.5358,483,021.581,581,692,026.281,255,009,882.62
  经营活动产生的现金流量净额25,683,735.92-45,633,648.04319,489,253.3681,517,901.55
二、投资活动产生的现金流量:
  收回投资收到的现金1,096,082,000269,082,0001,095,884,805.06604,883,045.68
  取得投资收益收到的现金24,822,613.712,128,399.0429,676,851.622,519,379.78
  处置固定资产、无形资产和其他长期资产收回的现金净额00424,655.96244,973.65
  收到的其他与投资活动有关的现金82,372,50038,412,500732,791,710.66632,790,000
  投资活动现金流入小计1,203,277,113.71309,622,899.041,858,778,023.281,260,437,399.11
  购建固定资产、无形资产和其他长期资产支付的现金17,310,726.828,798,807.78238,999,279.14172,105,488.81
  投资支付的现金1,055,560,000263,560,0001,632,290,379.04930,513,379.04
  支付其他与投资活动有关的现金70,000,0000624,806,188.61574,806,188.61
  投资活动现金流出小计1,142,870,726.82272,358,807.782,496,095,846.791,677,425,056.46
  投资活动产生的现金流量净额60,406,386.8937,264,091.26-637,317,823.51-416,987,657.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金500,000500,00000
  其中:子公司吸收少数股东投资收到的现金500,000500,00000
  取得借款收到的现金54,976,993.5348,979,000123,008,582.2882,511,520.09
  收到其他与筹资活动有关的现金004,902,171.3314,900,000
  筹资活动现金流入小计55,476,993.5349,479,000127,910,753.6197,411,520.09
  偿还债务支付的现金60,071,190.532,017,056.5158,049,036133,889,726
  分配股利、利润或偿付利息支付的现金2,374,096.351,185,655.368,457,272.672,828,231.18
  支付其他与筹资活动有关的现金2,030,197.09360,718.795,958,076.351,002,486.86
  筹资活动现金流出小计64,475,483.9433,563,430.65172,464,385.02137,720,444.04
  筹资活动产生的现金流量净额-8,998,490.4115,915,569.35-44,553,631.41-40,308,923.95
四、汇率变动对现金及现金等价物的影响-1,410,104.33-720,604.91-1,331,249.4-887,822.91
五、现金及现金等价物净增加额75,681,528.076,825,407.66-363,713,450.96-376,666,502.66
  加:期初现金及现金等价物余额503,658,427.3503,658,427.3867,371,878.26867,371,878.26
  期末现金及现金等价物余额579,339,955.37510,483,834.96503,658,427.3490,705,375.6
补充资料:
  净利润-124,465,953.27--780,521,960.65-
  资产减值准备2,244,215.45-436,991,981.1-
  固定资产和投资性房地产折旧41,879,386.14-148,169,554.51-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧41,879,386.14-148,169,554.51-
  无形资产摊销60,762,124.61-142,837,743.93-
  长期待摊费用摊销24,188,311.17-20,199,265.52-
  处置固定资产、无形资产和其他长期资产的损失3,759.71--5,476,467.27-
  固定资产报废损失566,991.84-5,351,082.78-
  公允价值变动损失103,232,310.4--4,572,082.42-
  财务费用-6,270,832.6-4,185,770.56-
  投资损失-21,026,636.05--49,428,681.35-
  递延所得税-12,175,447.36-16,677,417.29-
  其中:递延所得税资产减少-752,776.01-14,036,475.42-
    递延所得税负债增加-11,422,671.35-2,640,941.87-
  存货的减少3,839,438.93-41,271,030.36-
  经营性应收项目的减少84,241,399.58-398,866,558.38-
  经营性应付项目的增加-91,212,116.14--178,571,032.01-
  其他0-0-
  债务转为资本0-0-
  一年内到期的可转换公司债券0-0-
  融资租入固定资产0-0-
  不涉及现金收支的投资和筹资活动金额其他项目--4,436,208.16-
  现金的期末余额579,339,955.37-503,658,427.3-
  减:现金的期初余额503,658,427.3-867,371,878.26-
  加:现金等价物的期末余额0-0-
  减:现金等价物的期初余额0-0-
  现金及现金等价物的净增加额75,681,528.07--363,713,450.96-
公告日期2026-08-292026-04-282026-04-282025-10-31
审计意见(境内)标准无保留意见
TOP↑